secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2021-11-04T23:59:59+00:00
Accession:  0001628280-21-021770
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ApolloMed Q3 revenue $227.1M (+26% YoY), raises FY guidance; appoints Brandon Sim Co-CEO
--------------------------------------------------------------------------------

- Q3 revenue $227.1M (+26% YoY); EPS diluted $0.74 (up 64%); net income attributable to ApolloMed $34.3M (up 105%).
- FY2021 guidance raised: revenue $751.5-758.5M, net income attributable $71.5-73.5M, adjusted EBITDA $168.5-170.5M.
- Brandon Sim appointed Co-CEO effective Nov 2; Kenneth Sim steps down as Co-CEO but remains Executive Chairman.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000162828021021770/0001628280-21-021770-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000162828021021770/ameh-20211104.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-021770

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer